Binding of von Willebrand factor to collagen type III: role of specific amino acids in the collagen binding domain of vWF and effects of neighboring domains
- PMID: 11154106
Binding of von Willebrand factor to collagen type III: role of specific amino acids in the collagen binding domain of vWF and effects of neighboring domains
Abstract
Binding of von Willebrand Factor (vWF) to sites of vascular injury is the first step of hemostasis. Collagen types I and III are important binding sites for vWF. We have previously determined the three-dimensional structure of the collagen binding A3 domain of vWF (Huizinga et al., Structure 1997; 5: 1147). We hypothesized that the top face of this domain might be the collagen-binding site. Based on this hypothesis, we made seven vWF mutants (D934A/S936A, V1040A/ V1042A, D1046A, D1066A, D1069A, D1069R, and R1074A). Collagen binding of these mutants was investigated in ELISA and with Surface Plasmon Resonance (BIAcore). In addition, we studied collagen binding of mutants lacking the A2 or D4 domains, which flank the A3 domain. In ELISA, all point mutants and deletion mutants bound to collagen in amounts similar to wild type (WT)-vWF. In the BIAcore we found that WT-vWF has an apparent KD for collagen of 1-7 nM on a subunit base. The apparent kinetic parameters of the point mutants and deletion mutants were not significantly different from WT-vWF, except for DA2-vWF, which had a lower KD. indicating that the A2 domain somehow modulates binding of vWF to collagen type III. Based on our results, we conclude that the amino acid residues mutated by us are not critically involved in the interaction between vWF and collagen type III, which suggests that the collagen binding site is not located on the top face of the A3 domain.
Similar articles
-
A3 domain is essential for interaction of von Willebrand factor with collagen type III.Thromb Haemost. 1996 Jun;75(6):950-8. Thromb Haemost. 1996. PMID: 8822592
-
von Willebrand factor without the A2 domain is resistant to proteolysis.Thromb Haemost. 1997 May;77(5):1008-13. Thromb Haemost. 1997. PMID: 9184419
-
Ser968Thr mutation within the A3 domain of von Willebrand factor (VWF) in two related patients leads to a defective binding of VWF to collagen.Thromb Haemost. 2001 Sep;86(3):848-54. Thromb Haemost. 2001. PMID: 11583318
-
Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.Acta Haematol. 2009;121(2-3):128-38. doi: 10.1159/000214853. Epub 2009 Jun 8. Acta Haematol. 2009. PMID: 19506359 Review.
-
Laboratory diagnosis and molecular classification of von Willebrand disease.Acta Haematol. 2009;121(2-3):71-84. doi: 10.1159/000214846. Epub 2009 Jun 8. Acta Haematol. 2009. PMID: 19506352 Review.
Cited by
-
The beta-defensin gallinacin-6 is expressed in the chicken digestive tract and has antimicrobial activity against food-borne pathogens.Antimicrob Agents Chemother. 2007 Mar;51(3):912-22. doi: 10.1128/AAC.00568-06. Epub 2006 Dec 28. Antimicrob Agents Chemother. 2007. PMID: 17194828 Free PMC article.
-
Cleavage of von Willebrand factor by granzyme M destroys its factor VIII binding capacity.PLoS One. 2011;6(9):e24216. doi: 10.1371/journal.pone.0024216. Epub 2011 Sep 1. PLoS One. 2011. PMID: 21909423 Free PMC article.
-
A Drosophila haemocyte-specific protein, hemolectin, similar to human von Willebrand factor.Biochem J. 2001 Oct 1;359(Pt 1):99-108. doi: 10.1042/0264-6021:3590099. Biochem J. 2001. PMID: 11563973 Free PMC article.
-
Bone physiology as inspiration for tissue regenerative therapies.Biomaterials. 2018 Dec;185:240-275. doi: 10.1016/j.biomaterials.2018.09.028. Epub 2018 Sep 17. Biomaterials. 2018. PMID: 30261426 Free PMC article. Review.
-
Propolis Modifies Collagen Types I and III Accumulation in the Matrix of Burnt Tissue.Evid Based Complement Alternat Med. 2013;2013:423809. doi: 10.1155/2013/423809. Epub 2013 May 28. Evid Based Complement Alternat Med. 2013. PMID: 23781260 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous